Latest Articles

Cancer survivors have a higher risk of cardiovascular disease

This suggests that survivors of cancer are a high-risk group that may need more aggressive cardiovascular disease prevention.

Life Scientist 01 July, 2022

Eye-opening biomarkers for autism and ADHD discovered

Recordings from the retina can identify distinct signals for both ADHD and ASD, providing a potential biomarker for each condition.

Life Scientist 30 June, 2022

Fine-tuning CAR T cell therapy to reduce side effects

Researchers fine-tuned the cells used in immunotherapy so that their activity is strong enough to eliminate cancer but not so strong that they generate toxic side effects.

Life Scientist 29 June, 2022

Recurrent pregnancy loss linked to stroke later in life

Women with a history of miscarriage and stillbirth have a higher risk of stroke in later life, according to new research.

Life Scientist 29 June, 2022

Many human genomes shaped by 'founder events'

The genomes of many human populations show evidence of so-called founder events, which occur when a small number of initial members start a new population and can lead to...

Life Scientist 27 June, 2022

Biotechnology
Bringing clinical trials to the home: a game changer for the sector

Bringing clinical trials to the home: a game changer for the sector

COVID-19 has forced Australia's pharmaceutical and healthcare companies to completely redesign how clinical trials are run.

Article 23 May, 2022
Health & Medical
Hypertension linked to irregular sleep, 'forever chemicals'

Hypertension linked to irregular sleep, 'forever chemicals'

An increased risk of high blood pressure has been linked to irregularities in sleep as well as to higher concentrations of per- and polyfluoroalkyl...

Article 21 June, 2022
Life Sciences
Fine-tuning CAR T cell therapy to reduce side effects

Fine-tuning CAR T cell therapy to reduce side effects

Researchers fine-tuned the cells used in immunotherapy so that their activity is strong enough to eliminate cancer but not so strong that they...

Article 29 June, 2022
Molecular Biology
Herpes virus modified to fight cancer

Herpes virus modified to fight cancer

Researchers have managed to deactivate the genes of the herpes virus that cause disease, thus rendering it suitable for treatment.

Article 08 June, 2022
Lab Technology
Automation and shared knowledge pave the way for the future

Automation and shared knowledge pave the way for the future

Automation is a vital component to fuel the labs of tomorrow, and to ensure that drug development continues at the rapid pace seen in response to...

Article 26 May, 2022
  • All content Copyright © 2022 Westwick-Farrow Pty Ltd